BC
EVH icon

Brookfield Corp’s Evolent Health EVH Stock Holding History

Brookfield Corp’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37,817
Closed -$1.15M – 251
2023
Q2 		$1.15M Sell
37,817
-23,698
-39% -$766K ﹤0.01% 457
2023
Q1 		$2M Sell
61,515
-81,304
-57% -$2.57M 0.01% 420
2022
Q4 		$4.01M Buy
142,819
+62,340
+77% +$1.79M 0.02% 293
2022
Q3 		$2.89M Sell
80,479
-27,128
-25% -$956K 0.01% 382
2022
Q2 		$3.31M Buy
107,607
+67,231
+167% +$1.96M 0.01% 323
2022
Q1 		$1.3M Buy
+40,376
New +$1.06M ﹤0.01% 461
2020
Q4 		– Sell
-32,128
Closed -$399K – 472
2020
Q3 		$399K Buy
+32,128
New +$378K ﹤0.01% 357

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Brookfield Corp's EVH Position: Q3 2023 in Review

Brookfield Corp sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 37,817 shares — an estimated $1.15M sold.

Brookfield Corp first reported a position in EVH in Q3 2020 and held it in 7 quarters. The position peaked at $4.01M in Q4 2022. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • Brookfield Corp reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 37,817 Evolent Health shares in Q3 2023, an estimated $1.15M.
  • Brookfield Corp first reported a position in Evolent Health in Q3 2020 and held it in 7 quarters.
  • Brookfield Corp's Evolent Health position peaked at $4.01M in Q4 2022.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.